NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) -- INVESTOR ALERT: Squitieri & Fearon LLP and Moore Law PLLC announce that purchasers or acquirers of NowRx, Inc. securities between February 1, 2022 through November 5, 2022, both dates inclusive (the "Class Period"), have until Saturday, January 23, 2026 to seek appointment as lead plaintiff of the NowRx Inc. class action lawsuit filed on November 4, 2025 and captioned JOSEPH MUELLER, individually and on behalf of all others similarly situated v. NOWRX, INC., CARY ...

Core Insights - Teladoc Health, Inc. is currently viewed as a promising digital health stock to consider for investment [1] - The company's Q3 earnings report revealed a decline in revenue primarily due to a reduction in BetterHelp's performance and a strategic pullback on marketing efforts [3] Financial Performance - Q3 revenue decreased as BetterHelp's segment shrank, leading to an 8% decline in the lower-margin segment, which resulted in a 16% drop in adjusted EBITDA to $69.9 million [3] - The GAAP loss widened due to non-cash charges and amortization rather than a significant drop in demand [4] - Integrated Care showed growth, but the profitability mix was unfavorable, with BetterHelp's margin at 1.6% compared to Integrated Care's 17.0% [3][4] Analyst Ratings - Evercore ISI analyst Elizabeth Anderson maintained an In-Line rating for Teladoc Health, adjusting the price target from $8.00 to $9.00 on October 8, then reverting it back to $8.00 on October 30 after the Q3 earnings call [2][4] Market Dynamics - International growth was reported at 12%, which partially offset a 5% decline in the U.S. market [4] - The company's guidance indicates a focus on disciplined growth, with expectations for modest Integrated Care growth and a slow rebuild of BetterHelp as insurance adoption shifts revenue strategies [4]

Core Insights - The telehealth platform experienced a significant revenue increase of 49%, reaching $599 million in the latest quarter [1] Financial Performance - Revenue rose to $599 million, marking a 49% increase compared to the previous quarter [1]

Core Insights - Teladoc (TDOC) shares increased by 10% to close at $9.46, driven by higher trading volume compared to typical sessions, and an overall gain of 8.2% over the past four weeks [1][2] Financial Performance - The company anticipates third-quarter revenue of $626.4 million, exceeding the Zacks Consensus Estimate of $625 million, with adjusted EBITDA projected at $69.9 million [2] - The expected quarterly loss is $0.26 per share, reflecting a year-over-year decline of 36.8%, while revenues are forecasted to be $625.2 million, down 2.4% from the previous year [3] Earnings Estimates - The consensus EPS estimate for the quarter has been revised 0.6% higher in the last 30 days, indicating a positive trend that typically correlates with stock price appreciation [4] - Empirical research suggests that trends in earnings estimate revisions are strongly linked to near-term stock price movements [3] Market Position - Teladoc holds a Zacks Rank of 2 (Buy), indicating a favorable outlook compared to other stocks in the medical services industry [5] - In contrast, Avantor, a peer in the same industry, has a Zacks Rank of 4 (Sell) and has seen a 2.2% decrease in its EPS estimate over the past month [6]

"Company†), a leading provider of technology-enabled mobile health and medical transportation services, today announced that it has acquired virtual care platform SteadyMD, Inc. Management will host a conference call and webcast on Tuesday, October 21 at 11:00 a.m. ET to discuss this acquisition. SteadyMD powers high-quality telehealth experiences for digital health companies, labs, pharmacies, employers, and other healthcare. NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) ("DocGo†or the ...

Core Viewpoint - Momentum investing focuses on "buying high and selling higher," contrasting with traditional strategies of "buying low and selling high" [1] Group 1: Momentum Investing Strategy - Investors following momentum investing often avoid undervalued stocks, believing that quicker profits can be made from trending stocks [1] - Identifying the right entry point for fast-moving stocks can be challenging, as they may lose momentum if future growth does not justify their high valuations [1] Group 2: Bargain Stocks with Momentum - Investing in bargain stocks that have recently shown price momentum may be a safer strategy [2] - The Zacks Momentum Style Score is useful for identifying strong momentum stocks, while the 'Fast-Paced Momentum at a Bargain' screen helps find attractively priced fast-moving stocks [2] Group 3: Teladoc (TDOC) Analysis - Teladoc (TDOC) has shown a price increase of 13.5% over the past four weeks, indicating growing investor interest [3] - TDOC has gained 6.1% over the past 12 weeks, demonstrating its ability to deliver positive returns over a longer timeframe [4] - The stock has a beta of 1.9, suggesting it moves 90% higher than the market in either direction, indicating fast-paced momentum [4] Group 4: Valuation and Earnings Estimates - TDOC has a Momentum Score of B, suggesting it is a favorable time to invest in the stock [5] - The stock has a Zacks Rank 1 (Strong Buy) due to upward revisions in earnings estimates, which typically attract more investors [6] - TDOC is trading at a Price-to-Sales ratio of 0.62, indicating it is relatively cheap, as investors pay only 62 cents for each dollar of sales [6] Group 5: Additional Investment Opportunities - Besides TDOC, there are other stocks that meet the criteria of the 'Fast-Paced Momentum at a Bargain' screen, presenting additional investment opportunities [7] - Investors can explore over 45 Zacks Premium Screens tailored to different investing styles to identify potential winning stocks [8]

Core Viewpoint - Teladoc (TDOC) has received an upgrade to a Zacks Rank 2 (Buy), indicating a positive outlook based on an upward trend in earnings estimates [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system is driven by changes in a company's earnings picture, which significantly influences stock price movements [2][4]. - An increase in earnings estimates typically leads to higher fair value calculations by institutional investors, resulting in buying or selling actions that affect stock prices [4]. Business Improvement Indicators - The rising earnings estimates for Teladoc suggest an improvement in the company's underlying business, which could lead to increased stock prices as investors respond positively [5][10]. - Over the past three months, the Zacks Consensus Estimate for Teladoc has increased by 7.3%, indicating a positive trend in earnings expectations [8]. Zacks Rank System Overview - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a strong historical performance, particularly for Zacks Rank 1 stocks, which have generated an average annual return of +25% since 1988 [7]. - Only the top 20% of Zacks-covered stocks receive a "Strong Buy" or "Buy" rating, highlighting their superior earnings estimate revision features [9][10].

Company Overview - LifeMD is a smaller player in the telehealth sector, positioning itself as a "direct-to-patient telehealth company" that offers a high-quality, cost-effective, and convenient way to access comprehensive virtual and in-home healthcare [1] Investment Insights - The focus on small-cap opportunities suggests a strategy aimed at finding asymmetric upside potential in the market, particularly through sustainable high dividend yields [2] - Key factors for investment consideration include insider buying, high insider ownership, a history of free cash flow growth, and substantial catalysts for turnaround [2] Analyst Position - The analyst has a beneficial long position in LifeMD shares, indicating confidence in the company's future performance [3]

Company Overview - LifeMD (NASDAQ: LFMD) is a smaller player in the telehealth sector, positioning itself as a "direct-to-patient telehealth company" that offers a high-quality, cost-effective, and convenient way to access comprehensive virtual and in-home healthcare [1] Investment Insights - The focus on small-cap opportunities suggests a strategy aimed at finding asymmetric upside potential in the market, particularly through sustainable high dividend yields [2] - Key investment criteria include insider buying, high insider ownership, a long history of free cash flow growth, and substantial catalysts for turnaround [2] Analyst Position - The analyst has a beneficial long position in LifeMD shares, indicating confidence in the company's future performance [3]

Core Points - Health Net is responding to the State of Emergency declared by Governor Newsom in Tuolumne County due to the TCU Lightning Complex Fires, prioritizing support for affected members and healthcare providers [1] - The company is offering emergency medication supplies and telehealth services at no cost for members unable to reach their primary care providers [2][4] - Health Net is providing various support services, including mental health counseling, social services, and financial assistance, to help members cope with the crisis [4] Member Support - Members can fill prescriptions at their original pharmacy if open; if not, they can obtain medications at out-of-network pharmacies without refill limitations [4] - Health Net offers 24/7 crisis support through Behavioral Health Services and telehealth services for members [2][4] - Access to local community resources is available through 2-1-1 or 211.org for additional support [2] Healthcare Provider Support - Healthcare providers can contact Health Net for assistance during the emergency [3] - The company is extending grace periods for notifications related to various healthcare services and waiving prior authorization requirements [4] - Health Net will authorize out-of-network services if local providers are unavailable and accept updated clinical documentation for continued care [4] Company Overview - Health Net, a subsidiary of Centene Corporation, has been operating in California for over 45 years, serving more than three million members with a network of over 117,000 providers [6] - The company offers a range of health plans and services, including behavioral health and substance abuse programs [6] - Health Net is committed to transforming community health and employs over 5,700 people in California [6]